These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4231458)

  • 1. Urokinase activation of plasminogen and spontaneous inactivation of the plasmin formed. A kinetic study.
    Berg W
    Thromb Diath Haemorrh; 1968 Mar; 19(1):145-60. PubMed ID: 4231458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of heparin on plasmin and plasminogen activation].
    Manmi S
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
    [No Abstract]   [Full Text] [Related]  

  • 4. A method to correct for the continuing activation during the second stage in a two-stage assay. Exemplified by urokinase activation of plasminogen determined by the lysis time method.
    Berg W
    Thromb Diath Haemorrh; 1968 Mar; 19(1):161-8. PubMed ID: 4231459
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
    Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
    [No Abstract]   [Full Text] [Related]  

  • 7. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
    Wang M; Wang J; Shao M; Wang M; Wang Y
    Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
    Wiman B; Wallén P
    Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR; Collen D
    Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation by invasive human pathogens.
    Boyle MD; Lottenberg R
    Thromb Haemost; 1997 Jan; 77(1):1-10. PubMed ID: 9031440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of the fibrinolytic system in the newborn].
    Schlegel N; Hurtaud-Roux MF; Beaufils F
    Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action and some properties of a tissue activator of plasminogen.
    McCall DC; Kline DL
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):116-26. PubMed ID: 16955970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic modulation of thrombopoietin activity: comparison of thrombin, plasmin, and urokinase.
    Reiner AP; Aramaki KM
    Thromb Haemost; 2000 Jun; 83(6):909-14. PubMed ID: 10896248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.